Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
McDonald's
MCD
|
+$770M |
| 2 |
Crown Castle
CCI
|
+$678M |
| 3 |
ATVI
Activision Blizzard
ATVI
|
+$557M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$437M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
+$305M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$1.22B |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$1.04B |
| 3 |
Amazon
AMZN
|
+$661M |
| 4 |
SHPG
Shire pic
SHPG
|
+$478M |
| 5 |
TWX
Time Warner Inc
TWX
|
+$457M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.25% |
| 2 | Consumer Discretionary | 17.77% |
| 3 | Healthcare | 14.23% |
| 4 | Communication Services | 13.04% |
| 5 | Financials | 10.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
INXN
401
DELISTED
Interxion Holding N.V.
INXN
| $20.9M | 0.02% |
456,762
+2,821
| +0.6% | +$122K |
|
|
OKS
402
DELISTED
Oneok Partners LP
OKS
| $20.9M | 0.02% |
408,861
-73,589
| -15% | -$3.73M |
|
|
X
403
DELISTED
US Steel
X
| $20.8M | 0.02% |
+938,845
| New | +$22.3M |
|
404
Newmont
NEM
$135B
| $20.6M | 0.02% |
636,496
+625,546
| +5,713% | +$21.1M |
|
|
FL
405
DELISTED
Foot Locker
FL
| $20.6M | 0.02% |
417,384
-16,255
| -4% | -$1.05M |
|
406
Shutterstock
SSTK
$221M
| $20.5M | 0.02% |
464,306
-8,619
| -2% | -$381K |
|
407
Reliance Steel & Aluminium
RS
$19.8B
| $20.4M | 0.02% |
280,529
-22,646
| -7% | -$1.69M |
|
408
Plains All American Pipeline
PAA
$18B
| $20.3M | 0.02% |
771,498
-1,299,120
| -63% | -$36M |
|
409
Celanese
CE
$4.94B
| $20.1M | 0.02% |
211,859
-1,221
| -0.6% | -$109K |
|
|
TEP
410
DELISTED
Tallgrass Energy Partners, LP
TEP
| $20.1M | 0.02% |
400,820
-872
| -0.2% | -$43.5K |
|
411
Insmed
INSM
$25.9B
| $20M | 0.02% |
1,167,265
-174
| -0% | -$2.97K |
|
|
SAGE
412
PUT
DELISTED
Sage Therapeutics
SAGE
| $19.7M | 0.02% |
247,200
| – | – |
|
|
INN
413
Summit Hotel Properties
INN
$654M
| $19.6M | 0.02% |
1,048,520
-478,842
| -31% | -$8.35M |
|
414
e.l.f. Beauty
ELF
$6.14B
| $19.5M | 0.02% |
716,794
+516,794
| +258% | +$13.8M |
|
|
VWR
415
DELISTED
VWR Corporation
VWR
| $19.3M | 0.02% |
584,588
-846,533
| -59% | -$26.5M |
|
416
Chemours
CC
$2.35B
| $19M | 0.02% |
500,859
-41,886
| -8% | -$1.65M |
|
417
Mueller Water Products
MWA
$3.81B
| $18.9M | 0.02% |
1,619,539
-44,166
| -3% | -$507K |
|
418
Sarepta Therapeutics
SRPT
$2.2B
| $18.9M | 0.02% |
560,959
-2,374
| -0.4% | -$77.3K |
|
419
Cousins Properties
CUZ
$4.85B
| $18.5M | 0.02% |
525,791
+4,565
| +0.9% | +$157K |
|
420
Ocular Therapeutix
OCUL
$2.28B
| $18.4M | 0.02% |
1,985,496
-1,231,385
| -38% | -$11.9M |
|
421
W.R. Berkley
WRB
$25.4B
| $18.3M | 0.02% |
890,764
-1,223,572
| -58% | -$24.8M |
|
|
ZEN
422
DELISTED
ZENDESK INC
ZEN
| $18.1M | 0.02% |
652,590
+12,175
| +2% | +$334K |
|
423
Warrior Met Coal
HCC
$5.65B
| $18.1M | 0.02% |
+1,055,532
| New | +$18.3M |
|
424
Enterprise Products Partners
EPD
$84.3B
| $17.8M | 0.02% |
658,305
+9,247
| +1% | +$251K |
|
|
CBIO
425
Crescent Biopharma
CBIO
$659M
| $17.8M | 0.02% |
+15,937
| New | +$13.2M |
|
Similar funds
Jennison Associates's Q2 2017 Portfolio in Review
As of Q2 2017, Jennison Associates held 698 positions worth $94.3B, up 1.1% from $93.2B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jennison Associates withdrew a net $3.11B in Q2 2017, closing 61 positions and reducing 332 holdings. Its most notable exit was NXP Semiconductors, an estimated $452M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Jennison Associates opened a new position in Newell Brands worth $125M.
- Jennison Associates's largest Q2 2017 buy was Newell Brands: 2,328,211 shares worth $125M.
- Jennison Associates added most to McDonald's in Q2 2017, an estimated $770M increase.
- Jennison Associates's biggest Q2 2017 reduction was Nike, cutting an estimated $1.22B.
- Jennison Associates fully exited NXP Semiconductors in Q2 2017, selling an estimated $452M.
- Jennison Associates's ten largest holdings make up 27% of its $94.3B portfolio in Q2 2017.
- Jennison Associates opened 62 new positions and closed 61 in Q2 2017.
- Jennison Associates's portfolio value rose 1.1% quarter-over-quarter to $94.3B.
Based on Jennison Associates's 13F filing for Q2 2017, filed 4 Aug 2017.